Advanced Hr Her Breast Cancer clinical trials

Explore recruiting advanced hr her breast cancer clinical trials.

Also recruiting in Europe

Advanced Hr Her Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with endocrine therapy in patients with advanced hormone receptor positive, HER2-negative breast cancer and other advanced solid tumors

Italy, Germany, France, Czechia, Denmark, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Hr Her Breast Cancer trials by city

Advanced Hr Her Breast Cancer in Toronto Advanced Hr Her Breast Cancer in Vancouver Advanced Hr Her Breast Cancer in Montreal Advanced Hr Her Breast Cancer in Calgary Advanced Hr Her Breast Cancer in Edmonton Advanced Hr Her Breast Cancer in Ottawa Advanced Hr Her Breast Cancer in Winnipeg Advanced Hr Her Breast Cancer in Quebec City Advanced Hr Her Breast Cancer in Hamilton Advanced Hr Her Breast Cancer in Kitchener Advanced Hr Her Breast Cancer in London Advanced Hr Her Breast Cancer in Halifax Advanced Hr Her Breast Cancer in New York Advanced Hr Her Breast Cancer in Los Angeles Advanced Hr Her Breast Cancer in Chicago Advanced Hr Her Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease